BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24953819)

  • 1. Development of novel azabenzofuran TRPA1 antagonists as in vivo tools.
    Copeland KW; Boezio AA; Cheung E; Lee J; Olivieri P; Schenkel LB; Wan Q; Wang W; Wells MC; Youngblood B; Gavva NR; Lehto SG; Geuns-Meyer S
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3464-8. PubMed ID: 24953819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of transient receptor potential ankyrin 1 by eugenol.
    Chung G; Im ST; Kim YH; Jung SJ; Rhyu MR; Oh SB
    Neuroscience; 2014 Mar; 261():153-60. PubMed ID: 24384226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricyclic 3,4-dihydropyrimidine-2-thione derivatives as potent TRPA1 antagonists.
    Gijsen HJ; Berthelot D; De Cleyn MA; Geuens I; Brône B; Mercken M
    Bioorg Med Chem Lett; 2012 Jan; 22(2):797-800. PubMed ID: 22222037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.
    Baraldi PG; Romagnoli R; Saponaro G; Aghazadeh Tabrizi M; Baraldi S; Pedretti P; Fusi C; Nassini R; Materazzi S; Geppetti P; Preti D
    Bioorg Med Chem; 2012 Mar; 20(5):1690-8. PubMed ID: 22325155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy.
    Koivisto A; Hukkanen M; Saarnilehto M; Chapman H; Kuokkanen K; Wei H; Viisanen H; Akerman KE; Lindstedt K; Pertovaara A
    Pharmacol Res; 2012 Jan; 65(1):149-58. PubMed ID: 22133672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPA1 antagonists as potential analgesic drugs.
    Andrade EL; Meotti FC; Calixto JB
    Pharmacol Ther; 2012 Feb; 133(2):189-204. PubMed ID: 22119554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardamonin, a Novel Antagonist of hTRPA1 Cation Channel, Reveals Therapeutic Mechanism of Pathological Pain.
    Wang S; Zhai C; Zhang Y; Yu Y; Zhang Y; Ma L; Li S; Qiao Y
    Molecules; 2016 Aug; 21(9):. PubMed ID: 27589700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced activation of the transient receptor potential channel TRPA1 by ajoene, an allicin derivative.
    Yassaka RT; Inagaki H; Fujino T; Nakatani K; Kubo T
    Neurosci Res; 2010 Jan; 66(1):99-105. PubMed ID: 19808063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse monoclonal antibodies to transient receptor potential ankyrin 1 act as antagonists of multiple modes of channel activation.
    Lee KJ; Wang W; Padaki R; Bi V; Plewa CA; Gavva NR
    J Pharmacol Exp Ther; 2014 Aug; 350(2):223-31. PubMed ID: 24893987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonist.
    Payrits M; Sághy É; Mátyus P; Czompa A; Ludmerczki R; Deme R; Sándor Z; Helyes Z; Szőke É
    Neuroscience; 2016 Jun; 324():151-62. PubMed ID: 26930003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of TRPA1 by luminal stimuli induces EP4-mediated anion secretion in human and rat colon.
    Kaji I; Yasuoka Y; Karaki S; Kuwahara A
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(7):G690-701. PubMed ID: 22207576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation.
    Chen J; Joshi SK; DiDomenico S; Perner RJ; Mikusa JP; Gauvin DM; Segreti JA; Han P; Zhang XF; Niforatos W; Bianchi BR; Baker SJ; Zhong C; Simler GH; McDonald HA; Schmidt RG; McGaraughty SP; Chu KL; Faltynek CR; Kort ME; Reilly RM; Kym PR
    Pain; 2011 May; 152(5):1165-1172. PubMed ID: 21402443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity.
    Schenkel LB; Olivieri PR; Boezio AA; Deak HL; Emkey R; Graceffa RF; Gunaydin H; Guzman-Perez A; Lee JH; Teffera Y; Wang W; Youngblood BD; Yu VL; Zhang M; Gavva NR; Lehto SG; Geuns-Meyer S
    J Med Chem; 2016 Mar; 59(6):2794-809. PubMed ID: 26942860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of methylglyoxal on human cardiac fibroblast: roles of transient receptor potential ankyrin 1 (TRPA1) channels.
    Oguri G; Nakajima T; Yamamoto Y; Takano N; Tanaka T; Kikuchi H; Morita T; Nakamura F; Yamasoba T; Komuro I
    Am J Physiol Heart Circ Physiol; 2014 Nov; 307(9):H1339-52. PubMed ID: 25172898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPA1 modulators in preclinical development.
    Viana F; Ferrer-Montiel A
    Expert Opin Ther Pat; 2009 Dec; 19(12):1787-99. PubMed ID: 19939193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Amino-4-arylthiazole compounds as TRPA1 antagonists (WO 2012085662): a patent evaluation.
    De Petrocellis L; Schiano Moriello A
    Expert Opin Ther Pat; 2013 Jan; 23(1):119-47. PubMed ID: 23126422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of functional TRPA1 receptor on human lung fibroblast and epithelial cells.
    Mukhopadhyay I; Gomes P; Aranake S; Shetty M; Karnik P; Damle M; Kuruganti S; Thorat S; Khairatkar-Joshi N
    J Recept Signal Transduct Res; 2011 Oct; 31(5):350-8. PubMed ID: 21848366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the biology and medicinal chemistry of TRPA1.
    Rech JC; Eckert WA; Maher MP; Banke T; Bhattacharya A; Wickenden AD
    Future Med Chem; 2010 May; 2(5):843-58. PubMed ID: 21426205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
    Nakao S; Mabuchi M; Wang S; Kogure Y; Shimizu T; Noguchi K; Tanaka A; Dai Y
    Bioorg Med Chem Lett; 2017 Jul; 27(14):3167-3172. PubMed ID: 28576617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of TRPA1 channels by the fatty acid amide hydrolase inhibitor 3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597).
    Niforatos W; Zhang XF; Lake MR; Walter KA; Neelands T; Holzman TF; Scott VE; Faltynek CR; Moreland RB; Chen J
    Mol Pharmacol; 2007 May; 71(5):1209-16. PubMed ID: 17314320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.